MorphoSys
Biotechnology ResearchBavaria, Germany51-200 Employees
MorphoSys is a German biotechnology research company based in Planegg, Bavaria. It operates within the biotechnology research sector and is considered a mid-sized firm. In 2024, a merger-related action transferred minority shares to its majority shareholder, Novartis BidCo Germany AG, reflecting a significant change in its ownership structure. The provided information does not detail MorphoSys's product or service offerings. Media coverage notes an association with pelabresib, a drug candidate linked to MorphoSys through its relationship with Novartis, with discussions about potential launch timing. The company is situated within the broader German biotech landscape and has been involved in corporate developments connected to a major industry partner.